[1] |
蔡玲利, 钟森. 肺炎支原体肺炎的研究进展[J]. 河北医药, 2022, 44(11):1726-1731.
|
[2] |
CHEN J, JI F, YIN Y, et al. Time to Mycoplasma pneumoniae RNA clearance for wheezy vs. non-wheezy young children with community-acquired pneumonia[J]. J Trop Pediatr, 2021, 67(1):fmaa109.
|
[3] |
GE M, SONG Q, GUO Q, et al. Diagnostic value of serum ELISA of Mycoplasma pneumoniae IgM and IgG and passive particle agglutination for Mycoplasma pneumoniae pneumonia in children[J]. Clin Lab, 2021, 67(1):143-150.
|
[4] |
陈军莹, 姚德生, 贺婵娟, 等. 血清miR-21在诊断宫颈磷癌淋巴结转移中的价值[J]. 西安交通大学学报(医学版), 2012, 33(3):351-355.
|
[5] |
田伟, 梁淳, 宋亚娟. 肺炎支原体肺炎患儿血清microRNA-21和microRNA-221水平变化及与炎症因子、T淋巴细胞亚群的相关性[J]. 中国现代医学杂志, 2021, 31(19):19-24.
|
[6] |
SUN S, WANG F, SUN Y, et al. MiR-146a suppresses the expression of vascular endothelial growth factor and inflammatory responses in diabetic retinopathy[J]. Growth Factors, 2022, 40(3-4):89-97.
|
[7] |
WANG J, GUO C, YANG L, et al. Peripheral blood microR-146a and microR-29c expression in children with Mycoplasma pneumoniae pneumonia and its clinical value[J]. Ital J Pediatr, 2023, 49(1):119.
DOI
PMID
|
[8] |
中华医学会儿科学分会临床检验学组. 儿童肺炎支原体呼吸道感染实验室诊断中国专家共识[J]. 中华检验医学杂志, 2019, 42(7):507-513.
|
[9] |
倪萍, 张芙荣. 血清TLR4、IL-25、IL-33与小儿肺炎支原体肺炎病情的相关性及预测价值分析[J]. 徐州医科大学学报, 2024, 44(4):307-312.
|
[10] |
HU J, YE Y, CHEN X, et al. Insight into the pathogenic mechanism of Mycoplasma pneumoniae[J]. Curr Microbiol, 2022, 80(1):14.
|
[11] |
OLIVIERI F, PRATTICHIZZO F, GIULIANI A, et al. MiR-21 and miR-146a:the microRNAs of inflammaging and age-related diseases[J]. Ageing Res Rev, 2021, 70:101374.
|
[12] |
朱晓晨, 付迎新, 赵淑青, 等. 血清D-二聚体、IL-6、IL-18对儿童难治性肺炎支原体[J]. 临床与病理杂志, 2022, 42(2):376-381.
|
[13] |
何学联, 何子翼, 刘月阳, 等. 基于外周血炎症指标的列线图模型早期诊断新生儿败血症的价值[J]. 检验医学, 2022, 37(10):921-927.
DOI
|
[14] |
尚扬, 毛庆东, 郑兴. 麻杏石甘汤加味联合风热咳喘贴治疗小儿支原体肺炎的疗效及对C反应蛋白、白细胞介素8、血小板计数的影响[J]. 河北中医, 2022, 44(1):43-46.
|
[15] |
贺建龙, 朱彩艳, 白小云. 新生儿感染性肺炎hs-CRP、IL-8及血气分析联合诊断价值[J]. 贵州医药, 2022, 46(1):124-125.
|
[16] |
HIRANO T. IL-6 in inflammation,autoimmunity and cancer[J]. International immunology, 2021, 33(3):127-148.
|
[17] |
魏望, 薛存, 陆丹, 等. IL-1β、TLR4、CRP与新冠肺炎危重程度(CURB-65分级)相关性及预后影响因素分析[J]. 检验医学与临床, 2021, 18(13):1862-1865.
|
[18] |
李宏贵, 张莹, 黄蓓, 等. 硝黄散外敷联合加味五虎汤口服治疗痰热闭肺型肺炎支原体肺炎患儿对肺功能和血清TNF-α、IFN-γ、IL-4水平的影响[J]. 现代生物医学进展, 2022, 22(1):159-163.
|
[19] |
张娜, 李静, 闫晓静, 等. 病毒性脑炎患儿脑脊液IP-10、MCP-1检测的临床意义[J]. 检验医学, 2024, 39(5):454-457.
DOI
|
[20] |
梁淳, 尹蕾, 田伟. 肺炎支原体肺炎患儿血浆miR-223、miR-21水平变化及其与T淋巴细胞亚群、炎症因子的关系研究[J]. 国际检验医学杂志, 2021, 42(3):274-277.
|
[21] |
BHERE D, ARGHIANI N, LECHTICH E R, et al. Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy[J]. Sci Rep, 2020, 10(1):1779.
DOI
PMID
|
[22] |
哈宗兰, 马丽娜, 马琼, 等. miR-146a、miR-127对老年重症肺炎患者临床风险和预后的预测价值[J]. 中国急救复苏与灾害医学杂志, 2022, 17(9):1194-1197.
|
[23] |
MOUSSA AGHA D, ROUAS R, NAJAR M, et al. Impact of bone marrow miR-21 expression on acute myeloid leukemia T lymphocyte fragility and dysfunction[J]. Cells, 2020, 9(9):2053.
|